Similarly, LOXL1-ASI, another lncRNA markedly upregulated in CCA tissues, modulates the JAK2-STAT3 pathway by affecting JAK2 ubiquitination and subsequent degradation [64]. The gene discussed is JAK2; the disease is cholangiocarcinoma.